Clinical Trial Detail

NCT ID NCT04336982
Title A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Celgene
Indications

acute myeloid leukemia

Therapies

Azacitidine + CC-90009 + Venetoclax

CC-90009 + Gilteritinib

Age Groups: adult senior

Additional content available in CKB BOOST